MBP metabolic pharmaceuticals limited
Add to My Watchlist 3.23% ! 3.0¢

Keep in mind the results from the ACV1 phase 2A trial are due...

  1. poptop
    749 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    10/01/07
    13:20
    Post #: 2101626
    Keep in mind the results from the ACV1 phase 2A trial are due this half also

    I would even suggest to metabolic that they change their name to reflect their wider drug portfolio
    MBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Veteran executive to help turn Trigg into leading US-based antimony producer
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.